Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy

Breast Journal

Volumn 12, Issue 2, 2006, Pages 130-137

  Akazawa, Kenji ^a,b   Tamaki, Yasuhiro ^a   Taguchi, Tetsuya ^a   Tanji, Yoshio ^a   Miyoshi, Yasuo ^a   Kim, Seung Jin ^a   Ueda, Satsuki ^a   Yanagisawa, Tetsu ^a   Sato, Yoshinobu ^a   Tamura, Shinichi ^a   Noguchi, Shinzaburo ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Breast cancer; Neoadjuvant chemotherapy; Three dimensional MRI; Ultrasonography

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; GADOLINIUM PENTETATE; PACLITAXEL; TAXANE DERIVATIVE; ANTINEOPLASTIC AGENT; TAXOID;

ADJUVANT CHEMOTHERAPY; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG RESPONSE; ECHOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MEASUREMENT; MINIMAL RESIDUAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME; TUMOR VOLUME; ADJUVANT THERAPY; BREAST TUMOR; CANCER STAGING; CLINICAL TRIAL; DECISION MAKING; LUNG CARCINOMA; MASTECTOMY; METHODOLOGY; PAGET NIPPLE DISEASE; PATHOLOGY; PATIENT CARE PLANNING; PREOPERATIVE CARE; SEGMENTAL MASTECTOMY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CYCLOPHOSPHAMIDE; DECISION MAKING; EPIRUBICIN; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MASTECTOMY; MASTECTOMY, SEGMENTAL; NEOADJUVANT THERAPY; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PACLITAXEL; PATIENT CARE PLANNING; PREOPERATIVE CARE; TAXOIDS;

EID: 33645452141     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2006.00220.x     Document Type: Article

References (33)

1. Fisher B Anderson S. Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. National Surgical Adjuvant Breast and Bowel Project. World J Surg 1994 18 63 69.
2. Fornage BD Toubas O Morel M. Clinical, mammographic, and sonographic determination of preoperative breast cancer size. Cancer 1987 60 765 71.
3. Kristoffersen Wiberg M Aspelin P Sylvan M Bone B. Comparison of lesion size estimated by dynamic MR imaging, mammography and histopathology in breast neoplasms. Eur Radiol 2003 13 1207 12.
4. Asgeirsson KS McCulley SJ Pinder SE Macmillan RD. Size of invasive breast cancer and risk of local recurrence after breast-conservation therapy. Eur J Cancer 2003 39 2462 69.
5. Hortobagyi GN Ames FC Buzdar AU et al. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 1988 62 2507 16.
6. Singletary SE McNeese MD Hortobagyi GN. Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma. Cancer 1992 69 2849 52.
7. Bonadonna G Veronesi U Brambilla C et al. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 1990 82 1539 45.
8. van der Hage JA van de Velde CJ Julien JP Tubiana-Hulin M Vandervelden C Duchateau L. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 2001 19 4224 37.
9. Fisher B Brown A Mamounas E et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 1997 15 2483 93.
10. Swain SM Sorace RA Bagley CS et al. Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res 1987 47 3889 94.
11. Fisher B Bryant J Wolmark N et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998 16 2672 85.
12. Bonadonna G Valagussa P Brambilla C et al. Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute. J Clin Oncol 1998 16 93 100.
13. Wolmark N Wang J Mamounas E Bryant J Fisher B. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 2001 30 96 102.
14. Rouzier R Extra JM Carton M et al. Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery. J Clin Oncol 2001 19 3828 35.
15. Vinnicombe SJ MacVicar AD Guy RL et al. Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation. Radiology 1996 198 333 40.
16. Cocconi G Di Blasio B Alberti G Bisagni G Botti E Peracchia G. Problems in evaluating response of primary breast cancer to systemic therapy. Breast Cancer Res Treat 1984 4 309 13.
17. Helvie MA Joynt LK Cody RL Pierce LJ Adler DD Merajver SD. Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy. Radiology 1996 198 327 32.
18. Huber S Wagner M Zuna I Medl M Czembirek H Delorme S. Locally advanced breast carcinoma: evaluation of mammography in the prediction of residual disease after induction chemotherapy. Anticancer Res 2000 20 1B 553 58.
19. Esserman L Hylton N Yassa L Barclay J Frankel S Sickles E. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 1999 17 110 19.
20. Malur S Wurdinger S Moritz A Michels W Schneider A. Comparison of written reports of mammography, sonography and magnetic resonance mammography for preoperative evaluation of breast lesions, with special emphasis on magnetic resonance mammography. Breast Cancer Res 2001 3 55 60.
21. Herrada J Iyer RB Atkinson EN Sneige N Buzdar AU Hortobagyi GN. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Clin Cancer Res 1997 3 1565 69.
22. Weatherall PT Evans GF Metzger GJ Saborrian MH Leitch AM. MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation. J Magn Reson Imaging 2001 13 868 75.
23. Abraham DC Jones RC Jones SE et al. Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer 1996 78 91 100.
24. Rieber A Zeitler H Rosenthal H et al. MRI of breast cancer: influence of chemotherapy on sensitivity. Br J Radiol 1997 70 452 58.
25. Rieber A Brambs HJ Gabelmann A Heilmann V Kreienberg R Kuhn T. Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol 2002 12 1711 19.
26. Partridge SC Gibbs JE Lu Y Esserman LJ Sudilovsky D Hylton NM. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 2002 179 1193 99.
27. Englmeier KH Hellwig G Griebel J Delorme S Siebert M Brix G. Dynamic MR-mammography in virtual reality. Stud Health Technol Inform 2003 94 72 78.
28. WHO Handbook for Reporting of Cancer Treatment. Publication no. 48.
29. Segel MC Paulus DD Hortobagyi GN. Advanced primary breast cancer: assessment at mammography of response to induction chemotherapy. Radiology 1988 169 49 54.
30. Chen AM Meric-Bernstam F Hunt KK et al. Breast conservation after neoadjuvant chemotherapy: the MD Anderson Cancer Center experience. J Clin Oncol 2004 22 2303 12.
31. Gilles R Guinebretiere JM Toussaint C et al. Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 1994 191 633 38.
32. Rosen EL Blackwell KL Baker JA et al. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol 2003 181 1275 82.
33. Hayes C Padhani AR Leach MO. Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed 2002 15 154 63.